Literature DB >> 22668123

Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.

Michael Levine1, Anne-Michelle Ruha.   

Abstract

Historically, treatment for schizophrenia focused on sedation. The advent of the typical antipsychotics resulted in treatment aimed specifically at the underlying disease, but these agents were associated with numerous adverse effects, and were not particularly effective at treatment of the negative symptoms of schizophrenia. As a result, numerous atypical agents have been developed over the past 2 decades, including several agents within the past 5 years. Overdose of antipsychotics remains quite common in Western society. In 2010, poison control centres in the US received nearly 43,000 calls related to atypical antipsychotics alone. Due to underreporting, the true incidence of overdose with atypical antipsychotics is likely much greater. Following overdose of an atypical antipsychotic, the clinical effects observed, such as CNS depression, tachycardia and orthostasis are largely predictable based on the unique receptor binding profile of the agent. This article, which focuses on the atypical antipsychotics commonly used in the treatment of schizophrenia, discusses the features commonly encountered in overdose. Specifically, agents that result in QT prolongation and the corresponding potential for torsades de pointes, as well as unique features encountered with the various medications are discussed. The diagnosis of this overdose is largely based on history. Routine use of drug screens is unlikely to be beneficial. The primary goal of management is aggressive supportive care. Patients with significant CNS depression with associated loss of airway reflexes and respiratory failure need advanced airway management. Hypotension should be treated first with intravenous fluids, with the use of direct acting vasopressors reserved for persistent hypotension. Benzodiazepines should be used for seizures, with barbiturates used for refractory seizures. Intravenous magnesium can be administered for patients with a corrected QT interval exceeding 500 milliseconds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668123     DOI: 10.2165/11631640-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  82 in total

Review 1.  Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications.

Authors:  Paul E Keck; Susan L McElroy
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

2.  Three-year experience with ziprasidone exposures.

Authors:  Frank LoVecchio; David Watts; P Eckholdt
Journal:  Am J Emerg Med       Date:  2005-07       Impact factor: 2.469

Review 3.  Olanzapine overdose in children and adolescents: two case reports and a review of the literature.

Authors:  Frank M Theisen; Justyna Grabarkiewicz; Christine Fegbeutel; Anja Hübner; Claudia Mehler-Wex; Helmut Remschmidt
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-12       Impact factor: 2.576

4.  Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases.

Authors:  N G M Hunfeld; E M Westerman; D J Boswijk; J A M de Haas; M J A M van Putten; D J Touw
Journal:  Ther Drug Monit       Date:  2006-04       Impact factor: 3.681

Review 5.  Psychotropic drugs and the ECG: focus on the QTc interval.

Authors:  Paul J Goodnick; Jason Jerry; Francisco Parra
Journal:  Expert Opin Pharmacother       Date:  2002-05       Impact factor: 3.889

Review 6.  Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up.

Authors:  Ying-Chieh Wang; Cheryl C H Yang; Ya-Mei Bai; Terry B J Kuo
Journal:  Neuropsychobiology       Date:  2008-08-05       Impact factor: 2.328

Review 8.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Iloperidone: in schizophrenia.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

10.  Olanzapine overdose: a series of analytically confirmed cases.

Authors:  Mary Morgan; L Peter Hackett; Geoffrey K Isbister
Journal:  Int Clin Psychopharmacol       Date:  2007-05       Impact factor: 1.659

View more
  8 in total

1.  Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Authors:  Kun-Po Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2017-12

2.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

3.  Clinical Practice Guidelines for Management of Medical Emergencies Associated with Psychotropic Medications.

Authors:  Sandeep Grover; Siddharth Sarkar; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

Review 4.  The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs.

Authors:  Mitra Habibi; Felecia Hart; Jacquelyn Bainbridge
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

Review 5.  The Individualized Management Approach for Acute Poisoning.

Authors:  Muneera Al-Jelaify; Suliman AlHomidah
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-05-12

Review 6.  Medical management of epileptic seizures: challenges and solutions.

Authors:  Anand K Sarma; Nabil Khandker; Lisa Kurczewski; Gretchen M Brophy
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-24       Impact factor: 2.570

7.  Delayed-Onset Seizure in a Mild Quetiapine Overdose: Report of a Case and Review of the Literature.

Authors:  Jason A Chen; Katherine M Unverferth; Erick H Cheung
Journal:  Case Rep Psychiatry       Date:  2018-05-15

8.  Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia.

Authors:  Verónica Gamón; Isabel Hurtado; José Salazar-Fraile; Gabriel Sanfélix-Gimeno
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.